Clinical Trials in Brazil / NCT06075901
Enrolling by invitation Not applicable

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

NCT06075901 · tracked via the Priya Life Science Brazil tracker
Phase
Not applicable
Started
2025-08-01
Last updated
2026-09-16

Condition(s) studied

HypertrophyMuscle Strength

Investigational drug(s) / intervention(s)

Tissue FlossingBlood Flow Restriction CuffTraining Protocol

Tissue Flossing: Tissue Flossing ia a elastic band that when applied exerts an external pressure above or below a muscle or joint of the extremities.

Blood Flow Restriction Cuff: Inflatable device that exerts an external pressure above a muscle or joint of the extremities.

Training Protocol: The lower limb resistance training protocol will follow that recommended in the study by Patterson et al. for resistance training, and will last 4 weeks, with 3 training sessions per week, with a day break between sessions.

Study summary

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Individuals who present one or more of the following characteristics will not be included: * 1 presence of any health condition that contraindicates or prevents exercise; * 2 diabetes and diagnosed high blood pressure; * 3 inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker; * 5 history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent lower limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months); * 6 use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications; * 7 having one or more risk factors predisposing to thromboembolism Exclusion Criteria: * Participants will be excluded from the study if they: * 1 have a health problem that does not allow them to continue; * 2 wish to leave the study; * 3 not sign the consent form

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Franciele Marques Vanderlei Presidente Prudente São Paulo

More Paulista University trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06075901 on ClinicalTrials.gov ↗ ← All trials in Brazil